USPTO serial 79437918
PULSE
Reviewed by CopyMark Law Group
Status 622
- Filing date
- —
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- TMO LAW OFFICE 121
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PULSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacturing of cell culture and cell therapy and gene edited cell therapy apparatus and equipment for others; custom manufacture of medicines; custom manufacture of biopharmaceuticals, namely, therapeutic cells, laboratory-modified cells, and gene edited cells to prevent or treat conditions or diseases that can be transferred into the body, for others; information, advice and consultancy in relation to all the aforesaid. | ACTIVE | — |
| 042 | Platform-as-a-service [PaaS] in the field of cell therapy, and cell therapy development; providing temporary use of a a web-based platform that offers tools, technologies, processes and data analysis capabilities for researchers and scientists to streamline the development and characterization of cell lines; providing temporary use of a technological platform for the manufacturing of cell-based therapies, including technology, processes, and data analytics capabilities for process optimization and quality control; platform-as-a-service [PaaS] for monitoring patient health; laboratory research in the field of biotechnology; scientific research, design and technological development services in biotechnology, the pharmaceutical and medical industry; scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy equipment and apparatus; scientific research, design and development of cell culture, cell therapy or gene edited cell therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; scientific consultation services in the field of biotechnology, specifically in relation to cell culture, cell therapy, or gene edited cell therapy manufacturing; providing information with respect to scientific research in the field of stem cells, cell therapy and edited cell gene therapy; initial set-up, configuration, and calibration, of scientific apparatus, machines and equipment used for cell culture, cell therapy and edited cell gene therapy; industrial biotechnology statistical analysis to extract insights from cell line development experiments and data; research and development in the field of cells, therapeutic cells, cell therapies, cellular therapies and gene edited cell therapies; culturing of cells for scientific research purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 16, 2026 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Mar 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 29, 2026 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 27, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |